Short answer · Medically reviewed summary · Last updated: 2026-05-08
Jarcho-Levin syndrome, also known as spondylocostal dysostosis, is an ultra-rare genetic disorder characterized by congenital vertebral and rib malformations. While exact global prevalence is unknown, it is estimated to affect fewer than 1 in 200,000 individuals, though this figure is likely an underestimate due to significant underdiagnosis and clinical variability. Is Jarcho-Levin syndrome considered a rare disease? Yes, Jarcho-Levin syndrome is classified as an ultra-rare condition.
What is the prevalence of Jarcho-Levin Syndrome?
Prevalence of Jarcho-Levin Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Jarcho-Levin syndrome, also known as spondylocostal dysostosis, is an ultra-rare genetic disorder characterized by congenital vertebral and rib malformations. While exact global prevalence is unknown, it is estimated to affect fewer than 1 in 200,000 individuals, though this figure is likely an underestimate due to significant underdiagnosis and clinical variability.
Is Jarcho-Levin syndrome considered a rare disease?
Yes, Jarcho-Levin syndrome is classified as an ultra-rare condition. Because the clinical presentation of Jarcho-Levin syndrome can range from mild skeletal abnormalities to severe respiratory compromise, many individuals remain undiagnosed or are misclassified under broader categories of spondylocostal dysostosis. Accurate epidemiological data is difficult to collect because registries often lack universal reporting standards.
How does Jarcho-Levin syndrome affect different populations?
The condition presents at birth (congenital) and affects both males and females. While no specific ethnic predilection is definitively proven, historical literature has noted clusters of Jarcho-Levin syndrome in certain populations, suggesting potential founder effects in specific genetic lineages. Current understanding of the condition includes:
- Onset: Symptoms are present at birth, primarily identified via chest imaging.
- Gender Distribution: There is no significant evidence suggesting a higher prevalence in one gender over another.
- Data Limitations: Because Jarcho-Levin syndrome is so rare, clinical databases often rely on small case series rather than large-scale population studies.
How does the DiseaseMaps community contribute to our knowledge?
Real-world insights are vital for rare conditions like Jarcho-Levin syndrome. Currently, 5 individuals with Jarcho-Levin syndrome have joined the DiseaseMaps.org community. These patient-reported experiences provide invaluable context regarding the diagnostic journey and long-term management that formal clinical literature may not fully capture.
Next steps
- Consult with a clinical geneticist to confirm a diagnosis through molecular testing.
- Regularly monitor respiratory function with a pediatric pulmonologist, as rib cage structure is a primary concern.
- Connect with others on DiseaseMaps.org to share management strategies and emotional support.
- Discuss participation in rare disease patient registries to help improve future epidemiological data.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Spondylocostal dysostosis.
- Orphanet: Rare disease database entry for Spondylocostal dysostosis.
- OMIM (Online Mendelian Inheritance in Man): Entry #609813 (Spondylocostal Dysostosis).
